Fabrazyme (Agalsidase beta Vials) 35mg

Fabrazyme (agalsidase beta) is an enzyme replacement therapy for Fabry disease, a rare genetic disorder. This 35mg vial formulation supports metabolic function. Store at 2-8°C to maintain potency. Consult a healthcare provider for suitability.

Strength

35mg

Pack Size

Storage

2-8°

Manufacturer / TM Owner

Sanofi

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Agalsidase beta is used as enzyme replacement therapy to treat Fabry disease, a condition that affects the body’s ability to break down certain fats. It helps manage symptoms related to this metabolic disorder by providing the missing enzyme. People often ask, 'what is Fabrazyme used for' when exploring treatment options for Fabry disease.

Side Effects

Fabrazyme works by replacing the deficient enzyme beta-galactosidase A, which helps reduce the buildup of fatty substances in tissues and organs. Patients may experience improved energy levels and reduced pain associated with Fabry disease. Individual responses to the medication can vary.

Precautions & Warnings

Fabrazyme should be handled and administered by a healthcare professional in a controlled setting. Keep vials refrigerated between 2-8°C and protect from light. Do not use if the solution is discolored or contains particles. Always follow medical guidance for storage and administration.

Avoid Interactions

Limited information is available on drug interactions with agalsidase beta. However, caution is advised when combining with other medications that may affect enzyme function. Always inform your healthcare provider about all medications and supplements you are taking.

Frequently Asked Questions

Fabrazyme is used to treat Fabry disease, a rare genetic disorder that affects the body's ability to metabolize certain fats.

Fabrazyme is administered via intravenous infusion by a healthcare professional in a clinical setting.

No, Fabrazyme must be stored refrigerated between 2-8°C to maintain its potency and effectiveness.

Common side effects may include infusion reactions such as fever, chills, or nausea. Always discuss side effects with a healthcare provider.

No, Fabrazyme is a prescription medication and must be administered under medical supervision.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.